Advances in Urothelial Carcinoma: Expert Insights to Guide Clinical Practice

Join us for an interactive presentation by Arjun Balar, MD, as he guides us through his thought process for selecting optimal first-line therapy for patients with advanced urothelial carcinoma.

Arjun Balar, MD Kaitlyn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 6, 2021 Expired: No longer available for credit

Join us for an interactive presentation by Arjun Balar, MD, as he discusses current treatment options for patients with advanced urothelial carcinoma after previous chemotherapy and immunotherapy.

Arjun Balar, MD Kaitlyn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 4, 2021 Expired: No longer available for credit

Join us for an interactive presentation by Arjun Balar, MD, on the role of biomarkers in urothelial cancer management.

Arjun Balar, MD Kaitlyn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 21, 2021 Expired: No longer available for credit

Join Arjun Balar, MD, for an interactive presentation on the role of immunotherapy in the management of localized urothelial cancer.

Arjun Balar, MD Kaitlyn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 23, 2021 Expired: No longer available for credit

Join us for an interactive presentation by Kaitlyn Francese, MSN, RN, OCN, on the nurse’s role in managing immune-related adverse events associated with the use of immune checkpoint inhibitors in urothelial cancer.

Arjun Balar, MD Kaitlyn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 28, 2021 Expired: May 27, 2022

Join us for an interactive presentation by Kaitlyn Francese, MSN, RN, OCN, discussing the risks and benefits of urothelial cancer treatments from the perspectives of the healthcare professional and the patient.

Arjun Balar, MD Kaitlyn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 28, 2021 Expired: May 27, 2022

In this commentary, bladder cancer expert Matthew Galsky, MD, answers questions on the use of immune checkpoint blockade in first-line treatment, switch maintenance, and adjuvant therapy.

Matthew Galsky, MD Released: November 19, 2020

Download slides by Arjun Balar, MD on the role of immunotherapy and chemotherapy as first-line treatment for patients with advanced urothelial cancer.

Arjun Balar, MD Released: May 6, 2021

Download slides by Arjun Balar, MD on the role of antibody-drug conjugates in advanced urothelial cancer following chemotherapy and immunotherapy.

Arjun Balar, MD Released: May 4, 2021

Download slides by Arjun Balar, MD on the role of biomarkers in urothelial cancer management and selection for treatment approaches.

Arjun Balar, MD Released: April 21, 2021

Download slides by Arjun Balar, MD on the role of immunotherapy in early stage urothelial cancer.

Arjun Balar, MD Released: April 23, 2021

Download slides by Kaitlyn Francese, MSN, RN, OCN on the optimal management of immune-related AEs for patients with advanced urothelial cancer who are treated with immune checkpoint inhibitor therapy.

Kaitlyn Francese, MSN, RN, OCN Released: May 28, 2021

Download slides by Kaitlyn Francese, MSN, RN, OCN on considerations from patients’ perspectives for available treatment strategies for patients with advanced urothelial cancer.

Kaitlyn Francese, MSN, RN, OCN Released: May 28, 2021

Gain key clinical insights fast, with this short slideset from CCO on the current and emerging treatment options for patients with bladder cancer.

Arjun Balar, MD Kaitlyn Francese, MSN, RN, OCN Released: June 2, 2021

This Interactive Decision Support Tool will let you compare your choice of therapy for patients with advanced bladder cancer with expert recommendations from Matthew Galsky, MD; Shilpa Gupta, MD; Matthew I. Milowsky, MD; Elizabeth R. Plimack, MD, MS; and Arlene O. Siefker-Radtke, MD.

Matthew Galsky, MD Shilpa Gupta, MD Matthew I. Milowsky, MD Elizabeth R. Plimack, MD, MS Arlene O. Siefker-Radtke, MD Released: July 19, 2021